Hospitalogy March 24, 2025
Half of every dollar spent on brand medicines goes to entities that play no role in the research, development, or manufacturing of those medicines. So where does all that money go?
In the complex prescription drug market, various stakeholders have leveraged convoluted pricing mechanisms to maximize their profits. With health care spending on the rise and a growing focus on patient affordability, scrutiny has intensified over who is truly benefiting.
A 2025 report published by the Berkeley Research Group (BRG) dug into this question and revealed that over $670 billion was spent on brand medicines – an increase of $39 billion from the previous year. However, most of this new spending is not going to the people who make...
Today's Sponsors
Today's Sponsor